Solid results in the first half of 2025 despite the prevailing environment . Revenue: €40 billion . Profit from recurring operations: €9 billion . Free cash flow: €4 billion
YAMAGATA, Japan, July 9, 2025 /PRNewswire/ -- At the forefront of high fashion and biomaterial innovation, Japanese biotech venture Spiber, a pioneer in man-made protein...